Creating a new method to reduce proteins in Chlamydia bacteria
Development of a novel protein depletion method in Chlamydia
['FUNDING_R21'] · UNIVERSITY OF CALIFORNIA-IRVINE · NIH-10782546
This study is exploring a new way to target and reduce certain proteins in the Chlamydia bacteria, which causes a common sexually transmitted infection, to help researchers learn more about how these proteins work and find better treatments.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA-IRVINE (nih funded) |
| Locations | 1 site (IRVINE, UNITED STATES) |
| Trial ID | NIH-10782546 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel method to deplete specific proteins in Chlamydia trachomatis, the bacterium responsible for the most common sexually transmitted infection in the U.S. By utilizing small RNAs to downregulate protein expression, the researchers aim to better understand the functions of essential genes in Chlamydia. The study will compare this new approach with existing methods like CRISPRi to determine its effectiveness in controlling protein levels. This could lead to innovative tools for studying Chlamydia and potentially developing new treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Chlamydia trachomatis infections.
Not a fit: Patients with other types of infections or those not infected with Chlamydia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for Chlamydia infections.
How similar studies have performed: Other research has shown success with similar genetic approaches, indicating potential for this novel method.
Where this research is happening
IRVINE, UNITED STATES
- UNIVERSITY OF CALIFORNIA-IRVINE — IRVINE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TAN, MING — UNIVERSITY OF CALIFORNIA-IRVINE
- Study coordinator: TAN, MING
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Infectious Disease Pathway, Infectious Diseases, Infectious Disorder